CADL
Candel Therapeutics Inc
10.20$
+0.5%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | 100.0% | 100.0% | – | – | 100.0% | – | – | – | – | – | – | – | |
| – | 17.6% | 14.1% | – | – | 24.5% | – | – | – | – | – | – | – | |
| – | 82.4% | -14.1% | – | – | -24.5% | – | – | – | – | – | – | – | |
| – | 391.1% | 231.0% | – | – | 481.7% | – | – | – | – | – | – | – | |
| – | 172.3% | 214.0% | – | – | 332.4% | – | – | – | – | – | – | – | |
| – | 563.4% | 444.9% | – | – | 814.1% | – | – | – | – | – | – | – | |
| – | -581.0% | -444.9% | – | – | -814.1% | – | – | – | – | – | – | – | |
| – | 37.9% | 36.4% | – | – | 39.0% | – | – | – | – | – | – | – | |
| – | -624.7% | -462.9% | – | – | -1,407.3% | – | – | – | – | – | – | – | |
| – | 21.7% | 11.7% | – | – | – | – | – | – | – | – | – | – | |
| – | -624.7% | -462.9% | – | – | -1,407.3% | – | – | – | – | – | – | – | |
| – | -563.4% | -412.4% | – | – | -1,343.8% | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.